Flow behavior of erythrocytes in microvessels and glass capillaries: effects of erythrocyte deformation and erythrocyte aggregation.
Flow behavior of erythrocytes in microvessels and glass capillaries with an inner diameter of 10-50 microns was compared in relation to erythrocyte deformation and erythrocyte aggregation. This study was focused on the formation of a marginal cell-free layer, and the thickness was determined using an image processor. Human erythrocytes were perfused through a part of microvascular networks isolated from rabbit mesentery and through glass capillaries. Erythrocyte deformability was modified by treating erythrocytes with diamide, diazene-dicarboxylic acid bis[N,N-dimethylamide], and erythrocyte aggregation was accelerated by adding dextran (with a molecular weight of 70,400) to the perfusion medium. The thickness of the cell-free layer increased with an increase of the inner diameter of flow channel, with lowering the hematocrit, and with increasing the flow velocity of erythrocytes, in both microvessels and glass capillaries. Furthermore, the thickness of cell-free layer decreased with decreasing erythrocyte deformability, while it increased with accelerating erythrocyte aggregation. However, the alteration of the cell-free layer in response to the changes of these hemorheological conditions was more sensitive in microvessels than in glass capillaries. The present study concludes that flow behavior of erythrocytes in microvessels is qualitatively similar to, but quantitatively different from those in glass capillaries, as far as evaluated by the change of the thickness of the marginal cell-free layer.
Suzuki
Y
Y
Department of Physiology, School of Medicine, Ehime University Shigenobu, Japan.
Tateishi
N
N
Soutani
M
M
Maeda
N
N
D000818:Animals; D001783:Blood Flow Velocity; D002196:Capillaries / Q000502:physiology*; D003911:Dextrans / Q000494:pharmacology; D003958:Diamide / Q000494:pharmacology; D004903:Erythrocyte Aggregation / Q000187:drug effects / Q000502:physiology*; D004906:Erythrocyte Count; D004907:Erythrocyte Deformability / Q000187:drug effects / Q000502:physiology*; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D006400:Hematocrit; D006801:Humans; D008643:Mesentery / Q000098:blood supply; D010952:Plasma Substitutes / Q000494:pharmacology; D011817:Rabbits; D013439:Sulfhydryl Reagents / Q000494:pharmacology
D003911:Dextrans; D010952:Plasma Substitutes; D013439:Sulfhydryl Reagents; D003958:Diamide